Related Experiment Video
Updated: Mar 21, 2026

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.8K
Transforming Oncology Care: Developing a Strategy and Measuring Success
Seminars in Oncology Nursing
|May 4, 2016
Summary
Performance measurement in health care requires strategic planning. Goal setting and metric selection are crucial for accountability and guiding change in oncology nursing practice.
Area of Science:
- Healthcare Management
- Nursing Practice
- Quality Improvement
Background:
- Oncology nurse leaders face challenges in adapting to future trends and fostering innovation.
- Developing a supportive practice environment is essential for advancing oncology nursing.
- Performance metrics are vital for assessing care processes and outcomes.
Purpose of the Study:
- To examine accountability and performance measurement in healthcare.
- To illustrate the link between goal setting, measurement, and strategic planning.
- To provide a framework for selecting relevant performance metrics.
Main Methods:
- Review of national reports and relevant literature.
- Analysis of institutional experiences in healthcare settings.
- Case study presentation to demonstrate strategic planning for metric selection.
Main Results:
- Strategic planning provides a framework for selecting performance metrics.
- Goal setting and measurement are interconnected for accountability.
- A formal process is needed to implement useful quality measures.
Conclusions:
- Performance metrics are essential for oncology nursing practice.
- Nurses need a structured approach to metric selection and implementation.
- Strategic planning supports excellence in patient-centered oncology care.
Related Concept Videos
Cancer Survival Analysis
819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine
1.8K
1.8K
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
1.7K
1.7K

